HCT 116 (Human colon cancer cell) cell lysate, HT-29 (Human colorectal adenocarcinoma cell) cell lysate, COLO205 (Human colon adenocarcinoma cell) cell lysate, MDA-MB-231 (Human breast cancer cell) cell lysate, Mouse colon tissue lysate, Mouse small intestine tissue lysate, Rat colon tissue lysate, Rat small intestine tissue lysate.
Conjugation
unconjugated
Clone Number
PSH26-74
Reactivity Data
Tested
Verified (internally validated)
Published
Reported in literature (not internally validated)
Predicted
Predicted reactive (based on sequence homology)
Not recommended
Not recommended (failed internal validation)
WB
IHC-P
FC
IF-Cell
IP
human
mouse
rat
green monkey
Product Features
Form
Liquid
Concentration
1 mg/mL.(The concentration of this product may be batch-dependent)
Lot Concentration Lookup
Storage Instructions
Store at 2-8℃. Avoid freeze.
Storage Buffer
PBS (pH7.4).
Isotype
IgG
Purification Method
Protein A affinity purified.
Application Dilution
WB
1:5,000
IHC-P
1:1,000-1:2,000
FC
1:1,000
Target
Function
CDCP1 (CUB-domain-containing protein 1) contains three extracellular CUB domains, a transmembrane domain, and two putative cytoplasmic tyrosine phosphorylation sites. Phosphorylation of the gp140 and p80 proteins is mediated by Src family kinases at various tyrosine residues, including Tyr 734. PTP family members mediate the desphosphorylation of CDCP1. The conversion of gp140 to p80 prolongs the phosphorylation state, which may affect signaling in epithelial wounds. CDCP1 acts as a marker for hematopoetic cells and also exhibits high expression in metastatic colon and breast tumors.
Background References
1. Khan T et al. CUB Domain-Containing Protein 1 (CDCP1) is a rational target for the development of imaging tracers and antibody-drug conjugates for cancer detection and therapy. Theranostics. 2022 Oct
2. Huang H et al. Targeting CDCP1 boost CD8+ T cells-mediated cytotoxicity in cervical cancer via the JAK/STAT signaling pathway. J Immunother Cancer. 2024 Oct
This data was developed using HA724639, the same antibody clone in a different buffer formulation. Western blot analysis of CDCP1 on different lysates with Rabbit anti-CDCP1 antibody (HA724639) at 1/5,000 dilution.
Lane 1: HCT 116 (Human colon cancer cell) cell lysate (15 µg/Lane)
Lane 2: HT-29 (Human colorectal adenocarcinoma cell) cell lysate (15 µg/Lane)
Lane 3: COLO205 (Human colon adenocarcinoma cell) cell lysate (15 µg/Lane)
Lane 4: MDA-MB-231 (Human breast cancer cell) cell lysate (15 µg/Lane)
Lane 5: MCF7 (Human breast cancer cell) cell lysate (15 µg/Lane)
Lane 6: Mouse colon tissue lysate (20 µg/Lane)
Lane 7: Mouse small intestine tissue lysate (20 µg/Lane)
Lane 8: Rat colon tissue lysate (20 µg/Lane)
Lane 9: Rat small intestine tissue lysate (20 µg/Lane)
Blocking: 5% NFDM/TBST, 1 hour at room temperature
Primary antibody: HA724639, 1/5,000 in primary antibody dilution buffer (K1803), overnight at 4 °C
Secondary antibody: Goat anti-Rabbit IgG-HRP (HA1001), 1/50,000 in 5% NFDM/TBST, 1 hour at room temperature
Predicted band size: 92.9 kDa
Observed band size: 140, 70 kDa
The molecular weight is consistent with the reference (PMID: 20551327).
This data was developed using HA724639, the same antibody clone in a different buffer formulation. Application: Immunohistochemistry (IHC-P)
Species: Human
Tissue: Breast cancer
Sample: Paraffin-embedded section